Cited by 1,052Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects

The DOI matches its Crossref record; 64 of the 68 references it cites were found in a registry or an index.

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Glass, M, Faull, R.L.M, Dragunow, M·1997·Neuroscience

DOI 10.1016/s0306-4522(96)00428-9

Open this paper in CoChat — free account

Abstract

The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB

Integrity signals

Registry

Crossref · 10.1016/s0306-4522(96)00428-9

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The Thalamus
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164
Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784
Laminar Organization of Thalamic Projections to the Rat Neocortex
Herkenham, M. A. (1980) · Science · doi:10.1126/science.7352263 · Cited by 595
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Health aspects of cannabis
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500

Show all 68 references

Research works printed but not linked: 9

Bidaut-Russell, 1989, Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, Adv. Biosci., 75, 165
Campbell, 1986, Delta-9-tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat detate gyrus, J. Pharmac. exp. Ther., 239, 941
Chen, 1993, Transient concentration of cannabinoid receptors in the cortex subplate zone during kitten post-natal development, Soc. Neurosci. Abstr., 19, 305
Devane, 1988, Determination and characterisation of a cannabinoid receptor in rat brain, Molec. Pharmac., 34, 605
Dewey, 1972, The effects of chronic administration of trans-delta-9-tetrahydorcannibinol on behaviour and the cardiovascular system of dogs, Archs int. Pharmacodyn. Thér., 198, 118
Edery, 1972, Structure activity relationships in the tetrahydrocanabinol species, Arzneimittel-Forshch., 22, 1995
Howlett, 1985, Cannabinoid inhibition of adenylate cyclase. Biochemistry of response in neuroblasta cell membrane, Molec. Pharmac., 27, 429
Howlett, 1986, Involvement of Gi in the inhibition of adenylate cyclase by cannabinoid drugs, Molec. Pharmac., 29, 307
Mendelson, 1976, Operant acquisition of marijuana by men, J. Pharmac. exp. Ther., 198, 42

Sorted by citations

Items 201–300 of 1,000

Brain activity of anandamide: a rewarding bliss?
Scherma, M., Masia, P., Satta, V., Fratta, W., Fadda, P., & Tanda, G. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0075-x · Cited by 114
Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
Dalton, V. S., Long, L. E., Weickert, C. S., & Zavitsanou, K. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.43 · Cited by 104
The Influence of Recency of Use on fMRI Response During Spatial Working Memory in Adolescent Marijuana Users
Schweinsburg, A. D., Schweinsburg, B. C., Lisdahl, K. M., McQueeny, T. M., Brown, S. A., & Tapert, S. F. (2010) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2010.10400703 · Cited by 102
Molecular Mechanism and Cannabinoid Pharmacology
Schurman, L. D., Lu, D., Kendall, D. A., Howlett, A. C., & Lichtman, A. H. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_298 · Cited by 110
Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani, S., Cuomo, V., & Piomelli, D. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.09.005 · Cited by 104
Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis.
Lovell, M. E., Akhurst, J., Padgett, C. R., Garry, M. I., & Matthews, A. J. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000326 · Cited by 111
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Abate, G., Uberti, D. L., & Tambaro, S. (2021) · Biology · doi:10.3390/biology10060542 · Cited by 103
Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using 18F-Labeled Inverse Agonist Radioligands
Terry, G. E., Hirvonen, J., Liow, J., Zoghbi, S. S., Gladding, R. L., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Felder, C. C., Morse, C. L., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.067074 · Cited by 101
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Reddy, D. S. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114237 · Cited by 102
Cannabidiol as a potential treatment for psychosis
Schubart, C. D., Sommer, I. E., Fusar‐Poli, P., de Witte, L. D., Kahn, R. S., & Boks, M. P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.002 · Cited by 105
CB1 cannabinoid receptor agonist WIN 55, 212-2 decreases intravenous cocaine self-administration in rats
Fattore, L. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00059-5 · Cited by 100
The cannabinoid system: a role in both the homeostatic and hedonic control of eating?
Harrold, J. A., & Williams, G. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2003942 · Cited by 100
Distribution of cannabinoid receptor 1 in the CNS of zebrafish
Lam, C. S., Rastegar, S., & Strähle, U. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.069 · Cited by 99
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors
Mukherjee, S., Adams, M., Whiteaker, K. L., Daza, A. V., Kage, K., Cassar, S. C., Meyer, M., & Yao, B. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.058 · Cited by 99
Effects of cannabis on cognitive function in patients with multiple sclerosis
Honarmand, K., Tierney, M. C., O'Connor, P. W., & Feinstein, A. (2011) · Neurology · doi:10.1212/wnl.0b013e318212ab0c · Cited by 101
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Golub, V. M., & Reddy, D. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_7 · Cited by 106
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed
(FEEDAP), E. P. O. A. A. P. O. S. U. I. A. F. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2011 · Cited by 98
Endocannabinoid System in First Trimester Placenta: Low FAAH and High CB1 Expression Characterize Spontaneous Miscarriage
Trabucco, E., Acone, G., Marenna, A., Pierantoni, R., Cacciola, G., Chioccarelli, T., Mackie, K., Fasano, S., Colacurci, N., Meccariello, R., et al. (2009) · Placenta · doi:10.1016/j.placenta.2009.03.015 · Cited by 98
Characterization of the Diarylether Sulfonylester (−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties
Mauler, F., Mittendorf, J., Horváth, E., & Vry, J. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.359 · Cited by 98
Conceptual issues in behavioral teratology and their application in determining long‐term sequelae of prenatal marihuana exposure
Fried, P. A. (2002) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00005 · Cited by 96
The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature
Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D. I., & Yücel, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990435 · Cited by 99
CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies
Zurolo, E., Iyer, A. M., Spliet, W. G. M., van Rijen, P. C., Troost, D., Gorter, J. A., & Aronica, E. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.004 · Cited by 101
Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
Basavarajappa, B. S., Nixon, R. A., & Arancio, O. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787847921 · Cited by 98
Cannabinoid1 Receptor in the Dorsal Vagal Complex Modulates Lower Oesophageal Sphincter Relaxation in Ferrets
Partosoedarso, E. R., Abrahams, T. P., Scullion, R. T., Moerschbaecher, J. M., & Hornby, P. J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042242 · Cited by 95
Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system
VINOD, K., Yalamanchili, R., XIE, S., COOPER, T., & Hungund, B. L. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.05.002 · Cited by 95
Anatomical Distribution of Receptors, Ligands and Enzymes in the Brain and in the Spinal Cord: Circuitries and Neurochemistry
Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 103
Dose-Related Modulation of Event-Related Potentials to Novel and Target Stimuli by Intravenous Δ9-THC in Humans
D’Souza, D. C., Fridberg, D. J., Skosnik, P. D., Williams, A. H., Roach, B. J., Singh, N. M., Carbuto, M., Elander, J., Martin, A. M. S., Pittman, B. P., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.8 · Cited by 96
Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
Alba, R. G., Barragán‐Iglesias, P., González‐Hernández, A., Valdez-Moráles, E. E., Granados‐Soto, V., Condés‐Lara, M., Rodríguez, M. G., & Marichal‐Cancino, B. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01496 · Cited by 95
Δ9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
Krowicki, Z. K., Moerschbaecher, J. M., Winsauer, P. J., Sivarao, D. V., & Hornby, P. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00165-x · Cited by 94
Disrupted striatal neuron inputs and outputs in Huntington's disease
Reiner, A. J., & Deng, Y. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12844 · Cited by 93
The endocannabinoid system as a target for the treatment of cannabis dependence
Clapper, J. R., Mangieri, R. A., & Piomelli, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.018 · Cited by 94
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes
Higuera‐Matas, A., Ucha, M., & Ambrosio, E. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.020 · Cited by 97
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
Aronne, L. J., Tonstad, S., Moreno, M., Gantz, I., Erondu, N., Suryawanshi, S., Molony, C. M., Sieberts, S. K., Nayee, J., Meehan, A. G., et al. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.21 · Cited by 90
Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder: Implications for Targeted Pharmacological Treatment
Bailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89
Endocannabinoid System: Chemical Characteristics and Biological Activity
Rezende, B., Alencar, A. K. N., de Bem, G. F., Fontes-Dantas, F. L., & Montes, G. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020148 · Cited by 108
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
Tambaro, S., & Bortolato, M. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912798842269 · Cited by 93
Residual effects of cannabis use in adolescent and adult brains — A meta-analysis of fMRI studies
Blest‐Hopley, G., Giampietro, V., & Bhattacharyya, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.008 · Cited by 93
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93
Opportunities for cannabis in supportive care in cancer
Kleckner, A. S., Kleckner, I. R., Kamen, C. S., Tejani, M. A., Janelsins, M. C., Morrow, G. R., & Peppone, L. J. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919866362 · Cited by 92
Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia
Tao, R., Li, C., Jaffe, A. E., Shin, J. H., Deep‐Soboslay, A., Yamin, R., Weinberger, D. R., Hyde, T. M., & Kleinman, J. E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0832-8 · Cited by 90
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system
Freundt-Revilla, J., Kegler, K., Baumgärtner, W., & Tipold, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181064 · Cited by 88
The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress
Corcoran, L., Roche, M., & Finn, D. P. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.003 · Cited by 90
Cannabinoid (CB1), GABAA and GABAB receptor subunit changes in the globus pallidus in Huntington's disease
Allen, K. L., Waldvogel, H. J., Glass, M., & Faull, R. L. M. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.02.001 · Cited by 86
Self-citation
Cannabis and neurodevelopment: implications for psychiatric disorders
Sundram, S. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.762 · Cited by 86
Endocannabinoids, cannabinoids and the regulation of anxiety
Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 91
The endocannabinoid system and the treatment of obesity
Pagotto, U., Vicennati, V., & Pasquali, R. (2005) · Annals of Medicine · doi:10.1080/07853890510037419 · Cited by 85
Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia
Rais, M., van Haren, N. E. M., Cahn, W., Schnack, H. G., Lepage, C., Collins, D. L., Evans, A. C., Pol, H. E. H., & Kahn, R. S. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.08.008 · Cited by 84
Characterization of the Endocannabinoid System in Early Human Pregnancy
Helliwell, R. J. A., Chamley, L., Blake-Palmer, K. G., Mitchell, M. D., Wu, J., Kearn, C. S., & Glass, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0388 · Cited by 84
Self-citation
The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2
Darmani, N. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01355-3 · Cited by 84
Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography
Sevy, S., Smith, G. S., Ma, Y., Dhawan, V., Chaly, T., Kingsley, P. B., Kumra, S., Abdelmessih, S., & Eidelberg, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1075-1 · Cited by 83
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear
Choi, K. H., Le, T., McGuire, J. L., Xing, G., Zhang, L., Li, H., Parker, C. C., Johnson, L. R., & Ursano, R. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.021 · Cited by 84
FAAH−/− Mice Display Differential Tolerance, Dependence, and Cannabinoid Receptor Adaptation After Δ9-Tetrahydrocannabinol and Anandamide Administration
Falenski, K. W., Thorpe, A. J., Schlosburg, J. E., Cravatt, B. F., Abdullah, R. A., Smith, T. H., Selley, D. E., Lichtman, A. H., & Sim‐Selley, L. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.44 · Cited by 82
Cannabinoids and emotionality: a neuroanatomical perspective
McLaughlin, R. J., & Gobbi, G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.052 · Cited by 84
Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
Morrison, P. D., Nottage, J. F., Stone, J. M., Bhattacharyya, S., Tunstall, N., Brenneisen, R., Holt, D., Wilson, D., Sumich, A. L., McGuire, P. K., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.222 · Cited by 83
Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison
Renard, J., Krebs, M., Jay, T. M., & Pen, G. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2865-z · Cited by 81
Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex
Eggan, S. M., Melchitzky, D. S., Sesack, S. R., Fish, K. N., & Lewis, D. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.011 · Cited by 83
Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output
Fitzgerald, M. L., Shobin, E., & Pickel, V. M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.004 · Cited by 80
Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain
Mato, S., Pazos, Á., & Valdizán, E. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01575-3 · Cited by 80
Cannabinoids: new promising agents in the treatment of neurological diseases.
Giacoppo, S., Mandolino, G., Galuppo, M., Bramanti, P., & Mazzon, E. (2014) · Molecules · doi:10.3390/molecules191118781 · Cited by 79
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Hillard, C. J., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 82
CB1 Cannabinoid Receptors Increase Neuronal Precursor Proliferation through AKT/Glycogen Synthase Kinase-3β/β-Catenin Signaling
Trazzi, S., Steger, M., Mitrugno, V. M., Bartesaghi, R., & Ciani, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043711 · Cited by 80
Cannabinoids enhance susceptibility of immature brain to ethanol neurotoxicity
Hansen, H. H., Krutz, B., Sifringer, M., Stefovska, V. G., Bittigau, P., Pragst, F., Marsicano, G., Lutz, B., & Ikonomidou, C. (2007) · Annals of Neurology · doi:10.1002/ana.21287 · Cited by 79
Incerta-thalamic Circuit Controls Nocifensive Behavior via Cannabinoid Type 1 Receptors
Wang, H., Dong, P., He, C., Feng, X.-Y., Huang, Y., Yang, W.-W., Gao, H.-J., Shen, X., Lin, S., Cao, S.-X., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.04.027 · Cited by 78
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
Haney, M., Vallée, M., Fabre, S., Collins, S. L., Zanese, M., Campistron, G., Arout, C. A., Foltin, R. W., Cooper, Z. D., Kearney-Ramos, T. E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02381-w · Cited by 84
Self-citation
Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite
Cooper, S. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.009 · Cited by 78
Involvement of the endocannabinoid system in reward processing in the human brain
van Hell, H. H., Jager, G., Bossong, M. G., Brouwer, A., Jansma, J. M., Zuurman, L., van Gerven, J., Kahn, R. S., & Ramsey, N. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2428-8 · Cited by 77
Does Cannabis Use Cause Declines in Neuropsychological Functioning? A Review of Longitudinal Studies
González, R., Pacheco‐Colón, I., Duperrouzel, J. C., & Hawes, S. W. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000789 · Cited by 77
Effect of Δ9‐tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans
Beaumont, H., Jensen, J. M., Carlsson, A., Ruth, M., Lehmann, A., & Boeckxstaens, G. E. (2008) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00010.x · Cited by 78
Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing
Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., Reid, M. A., González, R., Robinson, J. L., Laird, A. R., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117744995 · Cited by 81
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder
Neumeister, A., Seidel, J., Ragen, B., & Pietrzak, R. H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.012 · Cited by 76
Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users
Beale, C., Broyd, S. J., Chye, Y., Suo, C., Schira, M. M., Galettis, P., Martin, J. H., Yücel, M., & Solowij, N. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0047 · Cited by 82
Neurotransmission systems in Parkinson’s disease
Moghaddam, H. S., Zare-Shahabadi, A., Rahmani, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0068 · Cited by 78
The role of Cannabinoids in neurodegenerative diseases
Glass, M. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00162-2 · Cited by 76
Self-citation
Cannabinoids reduce symptoms of Tourette?s syndrome
Müller‐Vahl, K. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1717 · Cited by 75
Cannabinoid modulation of time estimation in the rat.
Han, C. J., & Robinson, J. K. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.1.243 · Cited by 73
γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers
Prescot, A. P., Renshaw, P. F., & Yurgelun-Todd, D. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.02.028 · Cited by 73
Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies
Bossong, M. G., Jager, G., Bhattacharyya, S., & Allen, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990436 · Cited by 75
Positron Emission Tomography Shows Elevated Cannabinoid CB 1 Receptor Binding in Men with Alcohol Dependence
Neumeister, A., Normandin, M. D., Murrough, J. W., Henry, S. E., Bailey, C. R., Luckenbaugh, D. A., Tuit, K. L., Zheng, M., Galatzer‐Levy, I. R., Sinha, R., et al. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01815.x · Cited by 73
Modulation of Neurotransmission by Cannabinoids in the Basal Ganglia
Glass, M., Brotchie, J. M., & Maneuf, Y. P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01390.x · Cited by 73
Self-citation
Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure
Grewen, K., Salzwedel, A. P., & Gao, W. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00601 · Cited by 72
Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony
Carbonell, C. S., Rueda‐Orozco, P. E., Gómez, E. S., Buzsáki, G., Marsicano, G., & Robbe, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217144110 · Cited by 72
Confounders of excessive brain volume loss in schizophrenia
van Haren, N. E. M., Cahn, W., Pol, H. E. H., & Kahn, R. S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.006 · Cited by 72
Pharmacology and potential therapeutic uses of cannabis
Hirst, R. A., Lambert, D. G., & Notcutt, W. G. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.77 · Cited by 72
Chronic Pain and Psychiatric Conditions
Johnston, K. J. A., & Huckins, L. M. (2022) · Complex Psychiatry · doi:10.1159/000527041 · Cited by 81
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
Mangieri, R. A., & Piomelli, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.003 · Cited by 73
Phylogenomic and chemotaxonomic analysis of the endocannabinoid system
McPartland, J. M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.11.005 · Cited by 72
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder
de Almeida, C. M. O., Brito, M. M. C., Bosaipo, N. B., Pimentel, A. V., Tumas, V., Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., & Eckeli, A. L. (2021) · Movement Disorders · doi:10.1002/mds.28577 · Cited by 70
Cannabinoid Receptors: A brief history and "what's hot".
Graham, E. S. (2009) · Frontiers in bioscience · doi:10.2741/3288 · Cited by 71
Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of threat
Spechler, P. A., Orr, C., Chaarani, B., Kan, K., Mackey, S., Morton, A., Snowe, M. P., Hudson, K. E., Althoff, R. R., Higgins, S. T., et al. (2015) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2015.08.007 · Cited by 77
Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus
Ludányi, A., Hu, S. S., Yamazaki, M., Tanimura, A., Piomelli, D., Watanabe, M., Kano, M., Sakimura, K., Maglóczky, Z., Mackie, K., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.062 · Cited by 71
Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers
Antunes, H. K. M., Leite, G. S. F., Lee, K. S., Barreto, A. T., dos Santos, R. V. T., Souza, H. D. S., Tufik, S. B., & de Mello, M. T. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.01.028 · Cited by 77
The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain
Liang, Y.-C., Huang, C.-C., & Hsu, K.-S. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.019 · Cited by 68
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction
Hedlund, P. (2013) · Neurourology and Urodynamics · doi:10.1002/nau.22442 · Cited by 69
Altered CB1receptor‐signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine
Rodríguez‐Gaztelumendi, A., Rojo, M. L., Pazos, Á., & Díaz, Á. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05898.x · Cited by 68
Alteration to hippocampal shape in cannabis users with and without schizophrenia
Solowij, N., Walterfang, M., Lubman, D. I., Whittle, S., Lorenzetti, V., Styner, M. A., Velakoulis, D., Pantelis, C., & Yücel, M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.040 · Cited by 68
Endocannabinoids and the gastrointestinal tract: what are the key questions?
Sanger, G. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707422 · Cited by 68
Central effects of the cannabinoid receptor agonist WIN55212‐2 on respiratory and cardiovascular regulation in anaesthetised rats
Pfitzer, T., Niederhoffer, N., & Szabó, B. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705874 · Cited by 68
Effects of cannabinoid administration for pain: A meta-analysis and meta-regression.
Yanes, J. A., McKinnell, Z. E., Reid, M. A., Busler, J. N., Michel, J. S., Pangelinan, M. M., Sutherland, M. T., Younger, J., González, R., & Robinson, J. L. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000281 · Cited by 68
Cannabinoid–hormone interactions in the regulation of motivational processes
López, H. H. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.10.005 · Cited by 67
Neuropeptide Y Y1 and Y2 Receptor mRNA Expression in the Prefrontal Cortex of Psychiatric Subjects Relationship of Y2 Subtype to Suicidal Behavior
Caberlotto, L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00231-1 · Cited by 67

Authors: Glass, M., Faull, R. L. M., & Dragunow, M.
Affiliations: University of Auckland (NZ)
Corresponding author: Faull, R.L.M
ORCID: Glass, M
Faull, R.L.M
Dragunow, M
Venue: Neuroscience
Publisher: Elsevier BV
Published: 1997-02
Volume: 77
Issue: 2
Pages: 299-318
ISSN: 0306-4522 (ISSN-L)
DOI: 10.1016/s0306-4522(96)00428-9
OpenAlex: W2037811574
Cited by: 1,052
References: 68
Citations by year: 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
FWCI: 11.26
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
Keywords: cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
MeSH terms: Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks